Archives

by in
Entry Author Date Location
Bind Therapeutics, AstraZeneca Collaborate on Cancer Drug 04/22/13 Boston
Bind Therapeutics Reels Pfizer into Nanomedicine Partnership 04/03/13 Boston
East Coast Life Sciences Roundup: Bind, Boston Children’s, J&J, More 01/11/13 Boston
Mid-Priced Biotechnology Companies Bloom As M&A Targets in 2013 01/10/13 San Francisco
BIND CEO Says Amgen Deal Marks Nanomedicine Turning Point 01/09/13 Boston
Amgen in $180.5 Million Drug Development Deal with BIND Biosciences 01/08/13 Boston
Tech Tidbits: Akamai, Lilliputian Make Waves 09/14/12 Boston
Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases 03/19/12 Boston
The Thinking Behind Domain’s $760M Life Sciences Deal in Russia 03/07/12 San Diego
Repligen Buys Novozymes Unit, World Energy Acquires GSE Consulting, Alnylam Partners With GSK, & More Boston-Area Deals News 11/02/11 Boston
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News 10/28/11 Boston
BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs 10/27/11 Boston
BIND Biosciences Garners $4,750,000 New Funding Round 10/13/11 Boston
The Bob Langer and Polaris Family Tree: From Acusphere to Momenta to Visterra 04/19/11 Boston
Alkermes Finds New Home For Inhaled Drug-Delivery Tech with Civitas Spinout 01/10/11 Boston
Cerulean Pharma Makes Progress in Attacking the Big C with Tiny Drugs 09/07/10 Boston
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News 07/02/10 Boston
BIND Gets Backed by J&J Veteran’s VC Firm, SV Life Sciences Closes Fifth Fund, Boston Power Raises $60M, & More Boston-Area Deals News 06/30/10 Boston
Former J&J Group Chairman’s Firm Backs BIND Biosciences in $12.4M Round 06/29/10 Boston
BIND Biosciences Secures $1,400,000 Series C Financing 06/29/10 Boston
For Biotech and Pharma, Emerging Markets Offer Great Potential and Require New Strategies, Panelists Say 03/16/10 Boston
IkaSystems Raises $120M, New CEOs of Qteros, Bind, and Quanterix Dish the Dirt, & More Boston-Area Life Sciences News 01/20/10 Boston
A123Systems Invests in Fisker, Virtify Finds $15M, ATG Acquires InstantService, & More Boston-Area Deals News 01/18/10 Boston
Bonding with BIND Biosciences’s New CEO Scott Minick 01/15/10 Boston
Genzyme Reaches Agreement with Activist Investor, Charles River Closes Shrewsbury Lab, Lycera Comes to Cambridge, & More Boston-Area Life Sciences News 01/13/10 Boston
BIND Biosciences Secures $11,000,000 Series C Round 01/11/10 Boston
Aura Biosciences Aims to Develop “Ballistic Missile” Drug to Beat Pancreatic Cancer, Deliver RNAi Therapies 03/12/09 Boston
Selecta Biosciences Banks $15M to Advance Nano-Sized Immune-Stimulating Drugs 02/25/09 Boston
Inverness Buys Again, BIND Ties Up Some Dough, TurboPower Fires Up, Passport Systems Screens New Funds, and More 12/03/07 Boston
BIND Biosciences Raises $16 Million for Targeted, Drug-Loaded Nanoparticles 11/27/07 Boston
Page 1 of 2 next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Zillions of Biotech Conferences Want You. Which Should You Attend?
  4. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  5. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.